Endocrinology & Diabetes ResearchISSN: 2470-7570

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Editorial, J Metabonomics Metabolites Vol: 1 Issue: 2

Tryptophan Metabolism- Indoleamine 2,3-Dioxygenase- Friend and Foe

Nesrine Kamal Bassal, Bernard P Hughes* and Maurizio Costabile
University of South Australia, School of Pharmacy and Medical Sciences, Adelaide, Australia
Corresponding author : Bernard P Hughes, Ph.D
University of South Australia, School of Pharmacy and Medical Sciences, Adelaide, SA 5000, Australia
Tel: +61883022310;
Fax:
+61883022389; E-mail: [email protected]
Received: November 12, 2012 Accepted: November 14, 2012 Published: November 16, 2012
Citation: Bassal NK, Hughes BP, Costabile M (2012) Tryptophan Metabolism-Indoleamine 2,3-Dioxygenase- Friend and Foe. J Metabonomics Metabolites 1:2. doi:10.4172/2325-9736.1000e107

Abstract

Tryptophan Metabolism- Indoleamine 2,3-Dioxygenase- Friend and Foe

Indoleamine 2,3-dioxygenase (IDO) (EC 1.13.11.42) is a cytoplasmic, heme-containing enzyme that mediates the initial and rate-limiting step in the oxidative catabolism of the essential amino acid L-tryptophan (L-Trp). Recently, an additional IDO molecule, termed IDO2 has been identified. The gene encoding IDO2 is adjacent to the IDO gene. The IDO2 protein has a different expression profile to IDO and while it is able to metabolize L-Trp, IDO2 has a much higher Km for this substrate. In addition both enzymes differ in their selectivity for some inhibitors. Degradation of L-Trp via IDO leads to the production of several metabolites, including N-formyl-kynurenine and Kynurenine (Kyn).

Keywords:

Track Your Manuscript

Share This Page

Media Partners